Skip to main content
Premium Trial:

Request an Annual Quote

J&J to Use Gene Network Sciences Modeling Platform for Oncology Research

NEW YORK, March 7 (GenomeWeb News) - Gene Network Sciences said today that Johnson & Johnson Pharmaceutical Research & Development will use its computer-modeling technology as part of its cancer research efforts.

 

GNS said that J&JPRD will use its pathway inference technology and computer models to help identify pathways associated with the mechanism of action, biomarkers, and tumor specificity of a pre-clinical oncology compound.

 

Financial terms of the agreement were not disclosed.